Nuclear Medicine Radiopharmaceuticals Market Size, Share, Trends, Growth Report 2034

• Chapter 1. Preface
  • 1.1 Report Description and Scope
  • 1.2 Research scope
  • 1.3 Research methodology
    • 1.3.1 Market Research Type
    • 1.3.2 Market research methodology
• Chapter 2. Executive Summary
  • 2.1 Global Nuclear Medicine Radiopharmaceuticals Market, (2025 - 2034) (USD Billion )
  • 2.2 Global Nuclear Medicine Radiopharmaceuticals Market : snapshot
• Chapter 3. Global Nuclear Medicine Radiopharmaceuticals Market - Industry Analysis
  • 3.1 Nuclear Medicine Radiopharmaceuticals Market: Market Dynamics
  • 3.2 Market Drivers
    • 3.2.1 Advanced isotope production technologies and targeted delivery systems
  • 3.3 Market Restraints
    • 3.3.1. Regulatory complexity and safety concerns regarding radioactive materials
  • 3.4 Market Opportunities
    • 3.4.1. Emerging therapeutic applications and personalized medicine integration
  • 3.5 Market Challenges
    • 3.5.1. Supply chain limitations and isotope shortage issues
  • 3.6 Porter’s Five Forces Analysis
  • 3.7 Market Attractiveness Analysis
    • 3.7.1 Market attractiveness analysis By Product Type
    • 3.7.2 Market attractiveness analysis By Application
    • 3.7.3 Market attractiveness analysis By Distribution Channel
    • 3.7.4 Market attractiveness analysis By End User
• Chapter 4. Global Nuclear Medicine Radiopharmaceuticals Market- Competitive Landscape
  • 4.1 Company market share analysis
    • 4.1.1 Global Nuclear Medicine Radiopharmaceuticals Market: company market share, 2024
  • 4.2 Strategic development
    • 4.2.1 Acquisitions & mergers
    • 4.2.2 New Product launches
    • 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
    • 4.2.4 Research and development and Regional expansion
  • 4.3 Price trend analysis
• Chapter 5. Global Nuclear Medicine Radiopharmaceuticals Market - Product Type Analysis
  • 5.1 Global Nuclear Medicine Radiopharmaceuticals Market overview: By Product Type
    • 5.1.1 Global Nuclear Medicine Radiopharmaceuticals Market share, By Product Type, 2024 and 2034
  • 5.2 Diagnostic Radiopharmaceuticals
    • 5.2.1 Global Nuclear Medicine Radiopharmaceuticals Market by Diagnostic Radiopharmaceuticals, 2025 - 2034 (USD Billion )
  • 5.3 Therapeutic Radiopharmaceuticals
    • 5.3.1 Global Nuclear Medicine Radiopharmaceuticals Market by Therapeutic Radiopharmaceuticals, 2025 - 2034 (USD Billion )
  • 5.4 Enriched Stable Isotopes
    • 5.4.1 Global Nuclear Medicine Radiopharmaceuticals Market by Enriched Stable Isotopes, 2025 - 2034 (USD Billion )
  • 5.5 Medical Radioisotopes
    • 5.5.1 Global Nuclear Medicine Radiopharmaceuticals Market by Medical Radioisotopes, 2025 - 2034 (USD Billion )
• Chapter 6. Global Nuclear Medicine Radiopharmaceuticals Market - Application Analysis
  • 6.1 Global Nuclear Medicine Radiopharmaceuticals Market overview: By Application
    • 6.1.1 Global Nuclear Medicine Radiopharmaceuticals Market share, By Application, 2024 and 2034
  • 6.2 Oncology
    • 6.2.1 Global Nuclear Medicine Radiopharmaceuticals Market by Oncology, 2025 - 2034 (USD Billion )
  • 6.3 Cardiology
    • 6.3.1 Global Nuclear Medicine Radiopharmaceuticals Market by Cardiology, 2025 - 2034 (USD Billion )
  • 6.4 Neurology
    • 6.4.1 Global Nuclear Medicine Radiopharmaceuticals Market by Neurology, 2025 - 2034 (USD Billion )
  • 6.5 Nephrology
    • 6.5.1 Global Nuclear Medicine Radiopharmaceuticals Market by Nephrology, 2025 - 2034 (USD Billion )
• Chapter 7. Global Nuclear Medicine Radiopharmaceuticals Market - Distribution Channel Analysis
  • 7.1 Global Nuclear Medicine Radiopharmaceuticals Market overview: By Distribution Channel
    • 7.1.1 Global Nuclear Medicine Radiopharmaceuticals Market share, By Distribution Channel, 2024 and 2034
  • 7.2 Hospital Pharmacies
    • 7.2.1 Global Nuclear Medicine Radiopharmaceuticals Market by Hospital Pharmacies, 2025 - 2034 (USD Billion )
  • 7.3 Nuclear Pharmacies
    • 7.3.1 Global Nuclear Medicine Radiopharmaceuticals Market by Nuclear Pharmacies, 2025 - 2034 (USD Billion )
  • 7.4 Retail Pharmacies
    • 7.4.1 Global Nuclear Medicine Radiopharmaceuticals Market by Retail Pharmacies, 2025 - 2034 (USD Billion )
  • 7.5 Online Pharmacies
    • 7.5.1 Global Nuclear Medicine Radiopharmaceuticals Market by Online Pharmacies, 2025 - 2034 (USD Billion )
• Chapter 8. Global Nuclear Medicine Radiopharmaceuticals Market - End User Analysis
  • 8.1 Global Nuclear Medicine Radiopharmaceuticals Market overview: By End User
    • 8.1.1 Global Nuclear Medicine Radiopharmaceuticals Market share, By End User, 2024 and 2034
  • 8.2 Hospitals
    • 8.2.1 Global Nuclear Medicine Radiopharmaceuticals Market by Hospitals, 2025 - 2034 (USD Billion )
  • 8.3 Diagnostic Centers
    • 8.3.1 Global Nuclear Medicine Radiopharmaceuticals Market by Diagnostic Centers, 2025 - 2034 (USD Billion )
  • 8.4 Research Institutes
    • 8.4.1 Global Nuclear Medicine Radiopharmaceuticals Market by Research Institutes, 2025 - 2034 (USD Billion )
  • 8.5 Academic Centers
    • 8.5.1 Global Nuclear Medicine Radiopharmaceuticals Market by Academic Centers, 2025 - 2034 (USD Billion )
• Chapter 9. Nuclear Medicine Radiopharmaceuticals Market - Regional Analysis
  • 9.1 Global Nuclear Medicine Radiopharmaceuticals Market Regional Overview
  • 9.2 Global Nuclear Medicine Radiopharmaceuticals Market Share, by Region, 2024 & 2034 (USD Billion )
  • 9.3. North America
    • 9.3.1 North America Nuclear Medicine Radiopharmaceuticals Market, 2025 - 2034 (USD Billion )
      • 9.3.1.1 North America Nuclear Medicine Radiopharmaceuticals Market, by Country, 2025 - 2034 (USD Billion )
  • 9.4 North America Nuclear Medicine Radiopharmaceuticals Market, by Product Type, 2025 - 2034
    • 9.4.1 North America Nuclear Medicine Radiopharmaceuticals Market, by Product Type, 2025 - 2034 (USD Billion )
  • 9.5 North America Nuclear Medicine Radiopharmaceuticals Market, by Application, 2025 - 2034
    • 9.5.1 North America Nuclear Medicine Radiopharmaceuticals Market, by Application, 2025 - 2034 (USD Billion )
  • 9.6 North America Nuclear Medicine Radiopharmaceuticals Market, by Distribution Channel, 2025 - 2034
    • 9.6.1 North America Nuclear Medicine Radiopharmaceuticals Market, by Distribution Channel, 2025 - 2034 (USD Billion )
  • 9.7 North America Nuclear Medicine Radiopharmaceuticals Market, by End User, 2025 - 2034
    • 9.7.1 North America Nuclear Medicine Radiopharmaceuticals Market, by End User, 2025 - 2034 (USD Billion )
  • 9.4. Europe
    • 9.4.2 Europe Nuclear Medicine Radiopharmaceuticals Market, 2025 - 2034 (USD Billion )
      • 9.4.2.1 Europe Nuclear Medicine Radiopharmaceuticals Market, by Country, 2025 - 2034 (USD Billion )
  • 9.4 Europe Nuclear Medicine Radiopharmaceuticals Market, by Product Type, 2025 - 2034
    • 9.4.1 Europe Nuclear Medicine Radiopharmaceuticals Market, by Product Type, 2025 - 2034 (USD Billion )
  • 9.5 Europe Nuclear Medicine Radiopharmaceuticals Market, by Application, 2025 - 2034
    • 9.5.1 Europe Nuclear Medicine Radiopharmaceuticals Market, by Application, 2025 - 2034 (USD Billion )
  • 9.6 Europe Nuclear Medicine Radiopharmaceuticals Market, by Distribution Channel, 2025 - 2034
    • 9.6.1 Europe Nuclear Medicine Radiopharmaceuticals Market, by Distribution Channel, 2025 - 2034 (USD Billion )
  • 9.7 Europe Nuclear Medicine Radiopharmaceuticals Market, by End User, 2025 - 2034
    • 9.7.1 Europe Nuclear Medicine Radiopharmaceuticals Market, by End User, 2025 - 2034 (USD Billion )
  • 9.5. Asia Pacific
    • 9.5.3 Asia Pacific Nuclear Medicine Radiopharmaceuticals Market, 2025 - 2034 (USD Billion )
      • 9.5.3.1 Asia Pacific Nuclear Medicine Radiopharmaceuticals Market, by Country, 2025 - 2034 (USD Billion )
  • 9.4 Asia Pacific Nuclear Medicine Radiopharmaceuticals Market, by Product Type, 2025 - 2034
    • 9.4.1 Asia Pacific Nuclear Medicine Radiopharmaceuticals Market, by Product Type, 2025 - 2034 (USD Billion )
  • 9.5 Asia Pacific Nuclear Medicine Radiopharmaceuticals Market, by Application, 2025 - 2034
    • 9.5.1 Asia Pacific Nuclear Medicine Radiopharmaceuticals Market, by Application, 2025 - 2034 (USD Billion )
  • 9.6 Asia Pacific Nuclear Medicine Radiopharmaceuticals Market, by Distribution Channel, 2025 - 2034
    • 9.6.1 Asia Pacific Nuclear Medicine Radiopharmaceuticals Market, by Distribution Channel, 2025 - 2034 (USD Billion )
  • 9.7 Asia Pacific Nuclear Medicine Radiopharmaceuticals Market, by End User, 2025 - 2034
    • 9.7.1 Asia Pacific Nuclear Medicine Radiopharmaceuticals Market, by End User, 2025 - 2034 (USD Billion )
  • 9.6. Latin America
    • 9.6.4 Latin America Nuclear Medicine Radiopharmaceuticals Market, 2025 - 2034 (USD Billion )
      • 9.6.4.1 Latin America Nuclear Medicine Radiopharmaceuticals Market, by Country, 2025 - 2034 (USD Billion )
  • 9.4 Latin America Nuclear Medicine Radiopharmaceuticals Market, by Product Type, 2025 - 2034
    • 9.4.1 Latin America Nuclear Medicine Radiopharmaceuticals Market, by Product Type, 2025 - 2034 (USD Billion )
  • 9.5 Latin America Nuclear Medicine Radiopharmaceuticals Market, by Application, 2025 - 2034
    • 9.5.1 Latin America Nuclear Medicine Radiopharmaceuticals Market, by Application, 2025 - 2034 (USD Billion )
  • 9.6 Latin America Nuclear Medicine Radiopharmaceuticals Market, by Distribution Channel, 2025 - 2034
    • 9.6.1 Latin America Nuclear Medicine Radiopharmaceuticals Market, by Distribution Channel, 2025 - 2034 (USD Billion )
  • 9.7 Latin America Nuclear Medicine Radiopharmaceuticals Market, by End User, 2025 - 2034
    • 9.7.1 Latin America Nuclear Medicine Radiopharmaceuticals Market, by End User, 2025 - 2034 (USD Billion )
  • 9.7. The Middle-East and Africa
    • 9.7.5 The Middle-East and Africa Nuclear Medicine Radiopharmaceuticals Market, 2025 - 2034 (USD Billion )
      • 9.7.5.1 The Middle-East and Africa Nuclear Medicine Radiopharmaceuticals Market, by Country, 2025 - 2034 (USD Billion )
  • 9.4 The Middle-East and Africa Nuclear Medicine Radiopharmaceuticals Market, by Product Type, 2025 - 2034
    • 9.4.1 The Middle-East and Africa Nuclear Medicine Radiopharmaceuticals Market, by Product Type, 2025 - 2034 (USD Billion )
  • 9.5 The Middle-East and Africa Nuclear Medicine Radiopharmaceuticals Market, by Application, 2025 - 2034
    • 9.5.1 The Middle-East and Africa Nuclear Medicine Radiopharmaceuticals Market, by Application, 2025 - 2034 (USD Billion )
  • 9.6 The Middle-East and Africa Nuclear Medicine Radiopharmaceuticals Market, by Distribution Channel, 2025 - 2034
    • 9.6.1 The Middle-East and Africa Nuclear Medicine Radiopharmaceuticals Market, by Distribution Channel, 2025 - 2034 (USD Billion )
  • 9.7 The Middle-East and Africa Nuclear Medicine Radiopharmaceuticals Market, by End User, 2025 - 2034
    • 9.7.1 The Middle-East and Africa Nuclear Medicine Radiopharmaceuticals Market, by End User, 2025 - 2034 (USD Billion )
• Chapter 10. Company Profiles
  • 10.1 Novartis AG
    • 10.1.1 Overview
    • 10.1.2 Financials
    • 10.1.3 Product Portfolio
    • 10.1.4 Business Strategy
    • 10.1.5 Recent Developments
  • 10.2 Cardinal Health Inc.
    • 10.2.1 Overview
    • 10.2.2 Financials
    • 10.2.3 Product Portfolio
    • 10.2.4 Business Strategy
    • 10.2.5 Recent Developments
  • 10.3 GE Healthcare
    • 10.3.1 Overview
    • 10.3.2 Financials
    • 10.3.3 Product Portfolio
    • 10.3.4 Business Strategy
    • 10.3.5 Recent Developments
  • 10.4 Curium Pharma
    • 10.4.1 Overview
    • 10.4.2 Financials
    • 10.4.3 Product Portfolio
    • 10.4.4 Business Strategy
    • 10.4.5 Recent Developments
  • 10.5 Lantheus Medical Imaging Inc.
    • 10.5.1 Overview
    • 10.5.2 Financials
    • 10.5.3 Product Portfolio
    • 10.5.4 Business Strategy
    • 10.5.5 Recent Developments
  • 10.6 Bayer AG
    • 10.6.1 Overview
    • 10.6.2 Financials
    • 10.6.3 Product Portfolio
    • 10.6.4 Business Strategy
    • 10.6.5 Recent Developments
  • 10.7 Bracco Imaging S.p.A.
    • 10.7.1 Overview
    • 10.7.2 Financials
    • 10.7.3 Product Portfolio
    • 10.7.4 Business Strategy
    • 10.7.5 Recent Developments
  • 10.8 Mallinckrodt plc
    • 10.8.1 Overview
    • 10.8.2 Financials
    • 10.8.3 Product Portfolio
    • 10.8.4 Business Strategy
    • 10.8.5 Recent Developments
  • 10.9 Eczacibasi-Monrol Nuclear Products
    • 10.9.1 Overview
    • 10.9.2 Financials
    • 10.9.3 Product Portfolio
    • 10.9.4 Business Strategy
    • 10.9.5 Recent Developments
  • 10.10 Advanced Accelerator Applications
    • 10.10.1 Overview
    • 10.10.2 Financials
    • 10.10.3 Product Portfolio
    • 10.10.4 Business Strategy
    • 10.10.5 Recent Developments
  • 10.11 Nordion Inc.
    • 10.11.1 Overview
    • 10.11.2 Financials
    • 10.11.3 Product Portfolio
    • 10.11.4 Business Strategy
    • 10.11.5 Recent Developments
  • 10.12 NTP Radioisotopes SOC Ltd.
    • 10.12.1 Overview
    • 10.12.2 Financials
    • 10.12.3 Product Portfolio
    • 10.12.4 Business Strategy
    • 10.12.5 Recent Developments
  • 10.13 ANSTO
    • 10.13.1 Overview
    • 10.13.2 Financials
    • 10.13.3 Product Portfolio
    • 10.13.4 Business Strategy
    • 10.13.5 Recent Developments
  • 10.14 IBA Molecular Imaging
    • 10.14.1 Overview
    • 10.14.2 Financials
    • 10.14.3 Product Portfolio
    • 10.14.4 Business Strategy
    • 10.14.5 Recent Developments
  • 10.15 Jubilant DraxImage Inc.
    • 10.15.1 Overview
    • 10.15.2 Financials
    • 10.15.3 Product Portfolio
    • 10.15.4 Business Strategy
    • 10.15.5 Recent Developments
  • 10.16 Positron Corporation
    • 10.16.1 Overview
    • 10.16.2 Financials
    • 10.16.3 Product Portfolio
    • 10.16.4 Business Strategy
    • 10.16.5 Recent Developments
  • 10.17 Siemens Healthineers AG
    • 10.17.1 Overview
    • 10.17.2 Financials
    • 10.17.3 Product Portfolio
    • 10.17.4 Business Strategy
    • 10.17.5 Recent Developments
  • 10.18 Triad Isotopes Inc.
    • 10.18.1 Overview
    • 10.18.2 Financials
    • 10.18.3 Product Portfolio
    • 10.18.4 Business Strategy
    • 10.18.5 Recent Developments
  • 10.19 Radiopharm Theranostics Ltd.
    • 10.19.1 Overview
    • 10.19.2 Financials
    • 10.19.3 Product Portfolio
    • 10.19.4 Business Strategy
    • 10.19.5 Recent Developments
  • 10.20 Telix Pharmaceuticals Limited
    • 10.20.1 Overview
    • 10.20.2 Financials
    • 10.20.3 Product Portfolio
    • 10.20.4 Business Strategy
    • 10.20.5 Recent Developments
  • 10.21 and others.
    • 10.21.1 Overview
    • 10.21.2 Financials
    • 10.21.3 Product Portfolio
    • 10.21.4 Business Strategy
    • 10.21.5 Recent Developments

Table Of Figures

• 1. Market research Type
• 2. Market research methodology
• 3. Global Nuclear Medicine Radiopharmaceuticals Market, 2025 - 2034 (USD Billion )
• 4. Porter’s Five Forces Analysis
• 5. Global Nuclear Medicine Radiopharmaceuticals Market attractiveness, By Product Type
• 6. Global Nuclear Medicine Radiopharmaceuticals Market attractiveness, By Application
• 7. Global Nuclear Medicine Radiopharmaceuticals Market attractiveness, By Distribution Channel
• 8. Global Nuclear Medicine Radiopharmaceuticals Market attractiveness, By End User
• 9. Global Nuclear Medicine Radiopharmaceuticals Market share by Product Type, 2025 and 2034 (USD Billion )
• 10. Global Nuclear Medicine Radiopharmaceuticals Market by Diagnostic Radiopharmaceuticals, 2025 - 2034 (USD Billion )
• 11. Global Nuclear Medicine Radiopharmaceuticals Market by Therapeutic Radiopharmaceuticals, 2025 - 2034 (USD Billion )
• 12. Global Nuclear Medicine Radiopharmaceuticals Market by Enriched Stable Isotopes, 2025 - 2034 (USD Billion )
• 13. Global Nuclear Medicine Radiopharmaceuticals Market by Medical Radioisotopes, 2025 - 2034 (USD Billion )
• 14. Global Nuclear Medicine Radiopharmaceuticals Market share by Application, 2025 and 2034 (USD Billion )
• 15. Global Nuclear Medicine Radiopharmaceuticals Market by Oncology, 2025 - 2034 (USD Billion )
• 16. Global Nuclear Medicine Radiopharmaceuticals Market by Cardiology, 2025 - 2034 (USD Billion )
• 17. Global Nuclear Medicine Radiopharmaceuticals Market by Neurology, 2025 - 2034 (USD Billion )
• 18. Global Nuclear Medicine Radiopharmaceuticals Market by Nephrology, 2025 - 2034 (USD Billion )
• 19. Global Nuclear Medicine Radiopharmaceuticals Market share by Distribution Channel, 2025 and 2034 (USD Billion )
• 20. Global Nuclear Medicine Radiopharmaceuticals Market by Hospital Pharmacies, 2025 - 2034 (USD Billion )
• 21. Global Nuclear Medicine Radiopharmaceuticals Market by Nuclear Pharmacies, 2025 - 2034 (USD Billion )
• 22. Global Nuclear Medicine Radiopharmaceuticals Market by Retail Pharmacies, 2025 - 2034 (USD Billion )
• 23. Global Nuclear Medicine Radiopharmaceuticals Market by Online Pharmacies, 2025 - 2034 (USD Billion )
• 24. Global Nuclear Medicine Radiopharmaceuticals Market share by End User, 2025 and 2034 (USD Billion )
• 25. Global Nuclear Medicine Radiopharmaceuticals Market by Hospitals, 2025 - 2034 (USD Billion )
• 26. Global Nuclear Medicine Radiopharmaceuticals Market by Diagnostic Centers, 2025 - 2034 (USD Billion )
• 27. Global Nuclear Medicine Radiopharmaceuticals Market by Research Institutes, 2025 - 2034 (USD Billion )
• 28. Global Nuclear Medicine Radiopharmaceuticals Market by Academic Centers, 2025 - 2034 (USD Billion )
• 29. Global Nuclear Medicine Radiopharmaceuticals Market share, by Region, 2025 and 2034
• 30. North America Nuclear Medicine Radiopharmaceuticals Market, 2025 - 2034 (USD Billion )
• 31. Europe Nuclear Medicine Radiopharmaceuticals Market, 2025 - 2034 (USD Billion )
• 32. Asia Pacific Nuclear Medicine Radiopharmaceuticals Market, 2025 - 2034 (USD Billion )
• 33. Latin America Nuclear Medicine Radiopharmaceuticals Market, 2025 - 2034 (USD Billion )
• 34. The Middle-East and Africa Nuclear Medicine Radiopharmaceuticals Market, 2025 - 2034 (USD Billion )

Table Of Tables

• 1. Global Nuclear Medicine Radiopharmaceuticals Market: Snapshot
• 2. Drivers of the Nuclear Medicine Radiopharmaceuticals Market: impact analysis
• 3. North America Nuclear Medicine Radiopharmaceuticals Market revenue, By Product Type, 2025 - 2034 (USD Billion )
• 4. North America Nuclear Medicine Radiopharmaceuticals Market revenue, By Application, 2025 - 2034 (USD Billion )
• 5. North America Nuclear Medicine Radiopharmaceuticals Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
• 6. North America Nuclear Medicine Radiopharmaceuticals Market revenue, By End User, 2025 - 2034 (USD Billion )
• 7. U.S. Nuclear Medicine Radiopharmaceuticals Market revenue, By Product Type, 2025 - 2034 (USD Billion )
• 8. U.S. Nuclear Medicine Radiopharmaceuticals Market revenue, By Application, 2025 - 2034 (USD Billion )
• 9. U.S. Nuclear Medicine Radiopharmaceuticals Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
• 10. U.S. Nuclear Medicine Radiopharmaceuticals Market revenue, By End User, 2025 - 2034 (USD Billion )
• 11. Canada Nuclear Medicine Radiopharmaceuticals Market revenue, By Product Type, 2025 - 2034 (USD Billion )
• 12. Canada Nuclear Medicine Radiopharmaceuticals Market revenue, By Application, 2025 - 2034 (USD Billion )
• 13. Canada Nuclear Medicine Radiopharmaceuticals Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
• 14. Canada Nuclear Medicine Radiopharmaceuticals Market revenue, By End User, 2025 - 2034 (USD Billion )
• 15. Europe Nuclear Medicine Radiopharmaceuticals Market revenue, By Product Type, 2025 - 2034 (USD Billion )
• 16. Europe Nuclear Medicine Radiopharmaceuticals Market revenue, By Application, 2025 - 2034 (USD Billion )
• 17. Europe Nuclear Medicine Radiopharmaceuticals Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
• 18. Europe Nuclear Medicine Radiopharmaceuticals Market revenue, By End User, 2025 - 2034 (USD Billion )
• 19. Germany Nuclear Medicine Radiopharmaceuticals Market revenue, By Product Type, 2025 - 2034 (USD Billion )
• 20. Germany Nuclear Medicine Radiopharmaceuticals Market revenue, By Application, 2025 - 2034 (USD Billion )
• 21. Germany Nuclear Medicine Radiopharmaceuticals Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
• 22. Germany Nuclear Medicine Radiopharmaceuticals Market revenue, By End User, 2025 - 2034 (USD Billion )
• 23. France Nuclear Medicine Radiopharmaceuticals Market revenue, By Product Type, 2025 - 2034 (USD Billion )
• 24. France Nuclear Medicine Radiopharmaceuticals Market revenue, By Application, 2025 - 2034 (USD Billion )
• 25. France Nuclear Medicine Radiopharmaceuticals Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
• 26. France Nuclear Medicine Radiopharmaceuticals Market revenue, By End User, 2025 - 2034 (USD Billion )
• 27. U.K. Nuclear Medicine Radiopharmaceuticals Market revenue, By Product Type, 2025 - 2034 (USD Billion )
• 28. U.K. Nuclear Medicine Radiopharmaceuticals Market revenue, By Application, 2025 - 2034 (USD Billion )
• 29. U.K. Nuclear Medicine Radiopharmaceuticals Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
• 30. U.K. Nuclear Medicine Radiopharmaceuticals Market revenue, By End User, 2025 - 2034 (USD Billion )
• 31. Italy Nuclear Medicine Radiopharmaceuticals Market revenue, By Product Type, 2025 - 2034 (USD Billion )
• 32. Italy Nuclear Medicine Radiopharmaceuticals Market revenue, By Application, 2025 - 2034 (USD Billion )
• 33. Italy Nuclear Medicine Radiopharmaceuticals Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
• 34. Italy Nuclear Medicine Radiopharmaceuticals Market revenue, By End User, 2025 - 2034 (USD Billion )
• 35. Spain Nuclear Medicine Radiopharmaceuticals Market revenue, By Product Type, 2025 - 2034 (USD Billion )
• 36. Spain Nuclear Medicine Radiopharmaceuticals Market revenue, By Application, 2025 - 2034 (USD Billion )
• 37. Spain Nuclear Medicine Radiopharmaceuticals Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
• 38. Spain Nuclear Medicine Radiopharmaceuticals Market revenue, By End User, 2025 - 2034 (USD Billion )
• 39. Rest of Europe Nuclear Medicine Radiopharmaceuticals Market revenue, By Product Type, 2025 - 2034 (USD Billion )
• 40. Rest of Europe Nuclear Medicine Radiopharmaceuticals Market revenue, By Application, 2025 - 2034 (USD Billion )
• 41. Rest of Europe Nuclear Medicine Radiopharmaceuticals Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
• 42. Rest of Europe Nuclear Medicine Radiopharmaceuticals Market revenue, By End User, 2025 - 2034 (USD Billion )
• 43. Asia Pacific Nuclear Medicine Radiopharmaceuticals Market revenue, By Product Type, 2025 - 2034 (USD Billion )
• 44. Asia Pacific Nuclear Medicine Radiopharmaceuticals Market revenue, By Application, 2025 - 2034 (USD Billion )
• 45. Asia Pacific Nuclear Medicine Radiopharmaceuticals Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
• 46. Asia Pacific Nuclear Medicine Radiopharmaceuticals Market revenue, By End User, 2025 - 2034 (USD Billion )
• 47. China Nuclear Medicine Radiopharmaceuticals Market revenue, By Product Type, 2025 - 2034 (USD Billion )
• 48. China Nuclear Medicine Radiopharmaceuticals Market revenue, By Application, 2025 - 2034 (USD Billion )
• 49. China Nuclear Medicine Radiopharmaceuticals Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
• 50. China Nuclear Medicine Radiopharmaceuticals Market revenue, By End User, 2025 - 2034 (USD Billion )
• 51. Japan Nuclear Medicine Radiopharmaceuticals Market revenue, By Product Type, 2025 - 2034 (USD Billion )
• 52. Japan Nuclear Medicine Radiopharmaceuticals Market revenue, By Application, 2025 - 2034 (USD Billion )
• 53. Japan Nuclear Medicine Radiopharmaceuticals Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
• 54. Japan Nuclear Medicine Radiopharmaceuticals Market revenue, By End User, 2025 - 2034 (USD Billion )
• 55. India Nuclear Medicine Radiopharmaceuticals Market revenue, By Product Type, 2025 - 2034 (USD Billion )
• 56. India Nuclear Medicine Radiopharmaceuticals Market revenue, By Application, 2025 - 2034 (USD Billion )
• 57. India Nuclear Medicine Radiopharmaceuticals Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
• 58. India Nuclear Medicine Radiopharmaceuticals Market revenue, By End User, 2025 - 2034 (USD Billion )
• 59. South Korea Nuclear Medicine Radiopharmaceuticals Market revenue, By Product Type, 2025 - 2034 (USD Billion )
• 60. South Korea Nuclear Medicine Radiopharmaceuticals Market revenue, By Application, 2025 - 2034 (USD Billion )
• 61. South Korea Nuclear Medicine Radiopharmaceuticals Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
• 62. South Korea Nuclear Medicine Radiopharmaceuticals Market revenue, By End User, 2025 - 2034 (USD Billion )
• 63. South-East Asia Nuclear Medicine Radiopharmaceuticals Market revenue, By Product Type, 2025 - 2034 (USD Billion )
• 64. South-East Asia Nuclear Medicine Radiopharmaceuticals Market revenue, By Application, 2025 - 2034 (USD Billion )
• 65. South-East Asia Nuclear Medicine Radiopharmaceuticals Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
• 66. South-East Asia Nuclear Medicine Radiopharmaceuticals Market revenue, By End User, 2025 - 2034 (USD Billion )
• 67. Rest of Asia Pacific Nuclear Medicine Radiopharmaceuticals Market revenue, By Product Type, 2025 - 2034 (USD Billion )
• 68. Rest of Asia Pacific Nuclear Medicine Radiopharmaceuticals Market revenue, By Application, 2025 - 2034 (USD Billion )
• 69. Rest of Asia Pacific Nuclear Medicine Radiopharmaceuticals Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
• 70. Rest of Asia Pacific Nuclear Medicine Radiopharmaceuticals Market revenue, By End User, 2025 - 2034 (USD Billion )
• 71. Latin America Nuclear Medicine Radiopharmaceuticals Market revenue, By Product Type, 2025 - 2034 (USD Billion )
• 72. Latin America Nuclear Medicine Radiopharmaceuticals Market revenue, By Application, 2025 - 2034 (USD Billion )
• 73. Latin America Nuclear Medicine Radiopharmaceuticals Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
• 74. Latin America Nuclear Medicine Radiopharmaceuticals Market revenue, By End User, 2025 - 2034 (USD Billion )
• 75. Brazil Nuclear Medicine Radiopharmaceuticals Market revenue, By Product Type, 2025 - 2034 (USD Billion )
• 76. Brazil Nuclear Medicine Radiopharmaceuticals Market revenue, By Application, 2025 - 2034 (USD Billion )
• 77. Brazil Nuclear Medicine Radiopharmaceuticals Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
• 78. Brazil Nuclear Medicine Radiopharmaceuticals Market revenue, By End User, 2025 - 2034 (USD Billion )
• 79. Mexico Nuclear Medicine Radiopharmaceuticals Market revenue, By Product Type, 2025 - 2034 (USD Billion )
• 80. Mexico Nuclear Medicine Radiopharmaceuticals Market revenue, By Application, 2025 - 2034 (USD Billion )
• 81. Mexico Nuclear Medicine Radiopharmaceuticals Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
• 82. Mexico Nuclear Medicine Radiopharmaceuticals Market revenue, By End User, 2025 - 2034 (USD Billion )
• 83. Rest of Latin America Nuclear Medicine Radiopharmaceuticals Market revenue, By Product Type, 2025 - 2034 (USD Billion )
• 84. Rest of Latin America Nuclear Medicine Radiopharmaceuticals Market revenue, By Application, 2025 - 2034 (USD Billion )
• 85. Rest of Latin America Nuclear Medicine Radiopharmaceuticals Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
• 86. Rest of Latin America Nuclear Medicine Radiopharmaceuticals Market revenue, By End User, 2025 - 2034 (USD Billion )
• 87. The Middle-East and Africa Nuclear Medicine Radiopharmaceuticals Market revenue, By Product Type, 2025 - 2034 (USD Billion )
• 88. The Middle-East and Africa Nuclear Medicine Radiopharmaceuticals Market revenue, By Application, 2025 - 2034 (USD Billion )
• 89. The Middle-East and Africa Nuclear Medicine Radiopharmaceuticals Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
• 90. The Middle-East and Africa Nuclear Medicine Radiopharmaceuticals Market revenue, By End User, 2025 - 2034 (USD Billion )
• 91. GCC Countries Nuclear Medicine Radiopharmaceuticals Market revenue, By Product Type, 2025 - 2034 (USD Billion )
• 92. GCC Countries Nuclear Medicine Radiopharmaceuticals Market revenue, By Application, 2025 - 2034 (USD Billion )
• 93. GCC Countries Nuclear Medicine Radiopharmaceuticals Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
• 94. GCC Countries Nuclear Medicine Radiopharmaceuticals Market revenue, By End User, 2025 - 2034 (USD Billion )
• 95. South Africa Nuclear Medicine Radiopharmaceuticals Market revenue, By Product Type, 2025 - 2034 (USD Billion )
• 96. South Africa Nuclear Medicine Radiopharmaceuticals Market revenue, By Application, 2025 - 2034 (USD Billion )
• 97. South Africa Nuclear Medicine Radiopharmaceuticals Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
• 98. South Africa Nuclear Medicine Radiopharmaceuticals Market revenue, By End User, 2025 - 2034 (USD Billion )
• 99. Rest of Middle-East Africa Nuclear Medicine Radiopharmaceuticals Market revenue, By Product Type, 2025 - 2034 (USD Billion )
• 100. Rest of Middle-East Africa Nuclear Medicine Radiopharmaceuticals Market revenue, By Application, 2025 - 2034 (USD Billion )
• 101. Rest of Middle-East Africa Nuclear Medicine Radiopharmaceuticals Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion )
• 102. Rest of Middle-East Africa Nuclear Medicine Radiopharmaceuticals Market revenue, By End User, 2025 - 2034 (USD Billion )